NEW Our free Dividend Tracker is live — see what your stocks pay you
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

TCMD | NASDAQ

$23.28 -$0.24 | -1.02%
TREND SIGNAL:Signal available — unlock to view |2026-10-21

Next Earnings: Nov 02, 2026

Company Overview:

Market Cap: $527.35M
Trailing PE: 21.6x
FWD PE *: 20.9x
Payout Ratio (TTM): —
52-Week Range: $14.63 - $37.77

* Forward PE is based on street estimates.

10 Year TCMD Performance Metrics:

Total Return (with DRIP): 20.4% (1.88% CAGR)
Total Return (no DRIP): 20.4% (1.88% CAGR)
Share Price: 23.6% (2.14% CAGR)
Yield on Cost (with DRIP): —
Total Invested: $10,000
Total Value (with DRIP): $12,043
Total Return $ (with DRIP): $2,043
TCMD Total Return
1M 3M 6M YTD 1Y 3Y 5Y 10Y
TCMD Price Chart
1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan
PRO
$171/yr ($14.25/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $57/yr (25%)
Most Popular
PREMIUM
$288/yr ($24/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $96/yr (25%)
ULTRA
$576/yr ($48/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $192/yr (25%)

TCMD Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

TCMD - Revenue
TCMD Revenue CAGR:1Y: 8.61%2Y: 8.19%5Y: 10.91%10Y: 15.82%
TCMD - Earnings Per Share (EPS)
TCMD EPS CAGR:1Y: 142.86%2Y: 37.44%5Y: 37.18%10Y: 19.08%
TCMD - Net Income
🔓 See the full chart7-day free trial
TCMD Net Income CAGR:1Y: 142.00%2Y: 34.58%5Y: 42.93%10Y: 22.93%
TCMD - EBITDA
🔓 See the full chart7-day free trial
TCMD EBITDA CAGR:1Y: 39.51%2Y: 10.30%5Y: 75.09%10Y: 17.77%
TCMD - Free Cash Flow
🔓 See the full chart7-day free trial
TCMD Free Cash Flow CAGR:1Y: -86.53%2Y: -60.82%5Y: 0.00%10Y: 8.40%
TCMD - Free Cash Flow / Share
🔓 See the full chart7-day free trial
TCMD Free Cash Flow / Share CAGR:1Y: -85.91%2Y: -59.26%5Y: 0.00%10Y: 5.38%
TCMD - Operating Income
🔓 See the full chart7-day free trial
TCMD Operating Income CAGR:1Y: 67.18%2Y: 8.03%5Y: 0.00%10Y: 14.31%
TCMD - Gross Profit
🔓 See the full chart7-day free trial
TCMD Gross Profit CAGR:1Y: 11.15%2Y: 10.55%5Y: 12.54%10Y: 16.32%
TCMD - Shares Outstanding
🔓 See the full chart7-day free trial
TCMD Shares Outstanding CAGR:1Y: -0.77%2Y: -2.18%5Y: 2.84%10Y: 3.31%
TCMD - Share Buybacks
🔓 See the full chart7-day free trial
TCMD Share Buybacks CAGR:1Y: -68.06%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TCMD - Stock-Based Comp
🔓 See the full chart7-day free trial
TCMD Stock-Based Comp CAGR:1Y: 16.55%2Y: 10.23%5Y: -3.19%10Y: 40.57%
TCMD - Expenses
🔓 See the full chart7-day free trial
TCMD Expenses CAGR:1Y: 219.14%2Y: 53.60%5Y: 24.01%10Y: 18.40%
TCMD - Revenue vs Net Income
🔓 See the full chart7-day free trial
TCMD - EPS vs FCF / Share
🔓 See the full chart7-day free trial
TCMD - EPS vs PE Ratio
🔓 See the full chart7-day free trial
TCMD - FCF vs FCF / Share
🔓 See the full chart7-day free trial
TCMD - FCF vs Stock Based Comp
🔓 See the full chart7-day free trial
TCMD - Cash & Debt
🔓 See the full chart7-day free trial
TCMD - Revenue by Segment
🔓 See the full chart7-day free trial
TCMD Revenue CAGR:1Y: 8.61%2Y: 8.19%5Y: 10.91%10Y: 15.82%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

TCMD - REVENUE: Actual + Estimates
🔓 See the full chart7-day free trial
TCMD Actual Revenue CAGR:1Y: 8.61%2Y: 8.19%5Y: 10.91%10Y: 15.82%
TCMD - EPS: Actual + Estimates
🔓 See the full chart7-day free trial
TCMD Actual EPS CAGR:1Y: 142.86%2Y: 37.44%5Y: 37.18%10Y: 19.08%
TCMD - NET INCOME: Actual + Estimates
🔓 See the full chart7-day free trial
TCMD Actual Net Income CAGR:1Y: 142.00%2Y: 34.58%5Y: 42.93%10Y: 22.93%
TCMD - EBITDA: Actual + Estimates
🔓 See the full chart7-day free trial
TCMD Actual EBITDA CAGR:1Y: 39.51%2Y: 10.30%5Y: 75.09%10Y: 17.77%

Ratios, Profit Margins & Return on Capital:

TCMD - Net Profit Margin
🔓 See the full chart7-day free trial
TCMD Net Profit Margin CAGR:1Y: 122.55%2Y: 24.37%5Y: 28.82%10Y: 6.13%
TCMD - Gross Profit Margin
🔓 See the full chart7-day free trial
TCMD Gross Profit Margin CAGR:1Y: -7.82%2Y: -3.02%5Y: -0.64%10Y: -0.61%
TCMD - Price to Earnings
🔓 See the full chart7-day free trial
TCMD Price to Earnings CAGR:1Y: 20.93%2Y: 17.56%5Y: -35.50%10Y: -7.29%
TCMD - Price To Sales Ratio
🔓 See the full chart7-day free trial
TCMD Price To Sales Ratio CAGR:1Y: 165.54%2Y: 45.54%5Y: -17.04%10Y: -1.70%
TCMD - Return on Capital Employed
🔓 See the full chart7-day free trial
TCMD Return on Capital Employed CAGR:1Y: 61.11%2Y: 8.73%5Y: 0.00%10Y: -7.90%
TCMD - Return on Invested Capital
🔓 See the full chart7-day free trial
TCMD Return on Invested Capital CAGR:1Y: 129.51%2Y: 29.94%5Y: 34.95%10Y: -2.35%

Compare stocks side-by-side

Projected Future Returns & Dividends for TCMD

Based on past 10-year performance, here are TCMD growth metrics:

Share price CAGR of +2.14%
Dividend CAGR of +0%

Using TCMD CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

TCMD (DRIP)TCMD - No DRIP
Current Price$23.28$23.28
Start Shares429.55429.55
Start Value$10,000$10,000
  
After 10 years:
Final Share Count429.55429.55
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$23.28$23.28
Total Dividends$0$0
Final Value$10,000$10,000

Estimated Future Value + Dividends - TCMD

NOTE: Above numbers are our estimate based on TCMD's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan
PRO
$171/yr ($14.25/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $57/yr (25%)
Most Popular
PREMIUM
$288/yr ($24/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $96/yr (25%)
ULTRA
$576/yr ($48/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $192/yr (25%)

Company Info

Tactile Systems Technology, Inc. (TCMD) had its IPO on 2016-07-28, and is traded on NASDAQ stock exchange.

Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.

TCMD website: https://www.tactilemedical.com


Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan
PRO
$171/yr ($14.25/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $57/yr (25%)
Most Popular
PREMIUM
$288/yr ($24/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $96/yr (25%)
ULTRA
$576/yr ($48/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $192/yr (25%)
Loading signals…

DCF Model — TCMD

Value from:
Pay up to today
—
vs current price $23.28
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →